Key result
Right stellate ganglion blockade reduces pulmonary artery pressure and BP variability at high altitude.
Why the study?
Whether transient inhibition of sympathetic outflow with stellate ganglion blockade modifies pulmonary artery pressure and sympathetic arterial baroreflex regulation during high-altitude exposure in treated hypertension remained to be explored.
Does right ultrasound-guided stellate ganglion blockade modify pulmonary artery pressure and sympathetic arterial baroreflex regulation during high-altitude exposure in an individual with treated hypertension?
Case Report (n=1)
Does right ultrasound-guided stellate ganglion blockade modify pulmonary artery pressure and sympathetic arterial baroreflex regulation during high-altitude exposure in an individual with treated hypertension?
In a single patient with treated hypertension exposed to high altitude, stellate ganglion blockade transiently reduced pulmonary artery systolic pressure and blood pressure variability while altering sympathetic baroreflex regulation.
May reduce pulmonary pressures and BP variability at altitude in treated hypertension; hypothesis-generating and requires confirmation before any clinical consideration.
In this case study, we explored whether transient inhibition of sympathetic outflow with stellate ganglion blockade (SGB) modifies pulmonary artery pressure and sympathetic arterial baroreflex regulation during high-altitude (HA) exposure in an individual with treated hypertension. Methods: A 44-year-old man with treated hypertension underwent physiological assessments at sea level (220 m) and after 5 to 8 days of exposure to HA (3,800 m). Pulmonary artery systolic pressure (PASP), muscle sympathetic nerve activity (MSNA), beat-by-beat blood pressure (BP), carotid artery diameter, and spontaneous sympathetic baroreflex function (integrative and mechanical components) were assessed at sea level and during HA exposure. During HA exposure, these measurements were obtained following right ultrasound-guided SGB and compared with subsequent time-control visits. Results: HA exposure increased PASP, MSNA, BP, and BP variability compared with sea level. SGB reduced PASP, whereas no meaningful change occurred during the time-control visit. BP variability was lower following SGB than during the control visit. The integrative sympathetic arterial baroreflex relationship appeared steeper following SGB, and the mechanical component demonstrated a greater slope than during the time-control visit, consistent with altered mechanical baroreceptor transduction. Conclusions: These observations suggest that regional sympathetic inhibition may exert distinct influences on pulmonary artery pressure and sympathetic baroreflex regulation during sustained high-altitude exposure in treated hypertension.
No takes yet. Share an insight, caveat, or question.
Ojikutu et al. (2026) conducted a case report in Treated hypertension at high altitude (n=1). Right ultrasound-guided stellate ganglion blockade (SGB) vs. Time-control visits was evaluated on Pulmonary artery systolic pressure (PASP), muscle sympathetic nerve activity (MSNA), beat-by-beat blood pressure (BP), and spontaneous sympathetic baroreflex function. Right ultrasound-guided stellate ganglion blockade at 3,800 m reduced pulmonary artery systolic pressure and BP variability while steepening the sympathetic baroreflex slope in 1 hypertensive man.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: